Group | RES (mg/kg) | n | Tumor weight/mg | Inhibitory rate % | Intra-group inhibitory rate% |
---|---|---|---|---|---|
HepG2 | 0 | 4 | 222.50 ± 22.5 |  |  |
HepG2 | 15 | 4 | 173.33 ± 33.3a | 22.11 | 22.11 |
CAV1 | 0 | 4 | 165.50 ± 10.2 a | 25.84 |  |
CAV1 | 15 | 4 | 92.50 ± 15.1b | 58.43 | 44.12 |
CAVM1 | 0 | 4 | 337.50 ± 20.6 a | -51.68 |  |
CAVM1 | 15 | 4 | 117.50 ± 12.5 b | 47.19 | 65.19 |
CAVM2 | 0 | 4 | 170.00 ± 18.9 a | 23.61 |  |
CAVM2 | 15 | 4 | 142.50 ± 15.1 b | 35.96 | 16.17 |
CAVRNAi | 0 | 2 | 247.50 ± 7.07 a | -11.21 |  |
CAVRNAi | 15 | 4 | 230.00 ± 6.80b | -3.37 | 7.07 |